Lung cancer staging

Journal of Surgical Research

Volumn 117, Issue 1, 2004, Pages 92-106

  Sihoe, Alan D L ^b   Yim, Anthony P C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Chest radiology; Imaging; Lung cancer staging; Molecular staging

Indexed keywords

ALGORITHM; AORTOPULMONARY SEPTAL DEFECT; BRONCHOSCOPY; CANCER INVASION; CANCER STAGING; CERVICAL LYMPH NODE; CONFERENCE PAPER; DIAGNOSTIC TEST; ENDOSCOPIC SURGERY; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LUNG CANCER; LUNG METASTASIS; MEDIASTINOSCOPY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORACOTOMY; TRANSBRONCHIAL BIOPSY; ULTRASOUND;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSONOGRAPHY; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MEDIASTINOSCOPY; MEDIASTINUM; NECK; NEOPLASM STAGING; THORACIC SURGERY, VIDEO-ASSISTED; THORACOTOMY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542298310     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.11.006     Document Type: Conference Paper

References (158)

1. Jernal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. Cancer. 52:2002;23.
2. Denoix P.F. Enquete permanent dans les centres antercancereux. Bull. Inst. Natl. Hyg. 1:1946;70.
3. Mountain C.F., Carr D.T., Anderson W.A. A system for the clinical staging of lung cancer. Am. J. Roentgenol. Radium Ther. Nucl. Med. 120:1974;130.
4. Mountain C.F. A new international staging system for lung cancer. Chest. 89:1986;225S.
5. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710.
6. Grondin S.C., Liptay M.J. Current concepts in the staging of non-small cell lung cancer. Surg. Oncol. 11:2002;181.
7. Cromartie R.S., Parker E.F., May J.E., Metcalf J.S., Bartles D.M. Carcinoma of the lung a clinical review. Ann. Thorac. Surg. 30:1980;30.
8. Hyde L., Hyde C.I. Clinical manifestations of lung cancer. Chest. 65:1974;299.
9. Silvestri G.A., Littenberg B., Colice G.L. The clinical evaluation for detecting metastatic lung cancer a meta-analysis. Am. J. Resp. Crit. Care Med. 152:1995;225.
10. Toloza E.M., Harpole L., McCrory D.C. Noninvasive staging of non-small cell lung cancer a review of the current evidence. Chest. 123:2003;137S.
11. Strauss G.M., Dominioni L. Lung cancer screening and the surgical oncologist the controversy. Surg. Oncol. Clin. North Am. 8:1999;371.
12. Silvestri G.A., Tanoue L.T., Margolis M.L., Barker J., Detterbeck F. The noninvasive staging of non-small cell lung cancer the guidelines. Chest. 123:2003;147S.
13. Patz E., Erasmus J., McAdams H.P., et al. Lung cancer staging and management comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology. 212:1999;56.
14. Cascade P.N., Gross B.H., Kazerooni E.A. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer a comparison of contrast-enhanced and unenhanced CT. Am. J.Roentgenol. 170:1998;927.
15. Venuta F., Rendina E.A., Ciriaco P., et al. Computed tomography for preoperative assessment of T3 and T4 bronchogenic carcinoma. Eur. J. Cardiothorac. Surg. 6:1992;238.
16. Martini N., Flehinger B.J., Zaman M.B., et al. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases. J. Thorac. Cardiovasc. Surg. 80:1980;390.
17. Dillemans B., Deneffe G., Verschakelen J., et al. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastina nodes in non-small cell lung cancer a study of 569 patients. Eur. J. Cardiothorac. Surg. 8:1994;37.
18. Nakanishi R., Yasumoto K. Combined thoracoscopy and mediastinoscopy for mediastinal lymph node staging of lung cancer. Int. Surg. 81:1996;359.
19. Arita T., Masumoto T., Kuramitsu T., et al. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest. 110:1996;1004.
20. Gdeedo A., Van Schil P., Corthouts B., et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur. Resp. J. 10:1997;1547.
21. Medina Gallardo J.F., Borderas Naranjo F., Torres Cansino M., et al. Validity of enlarged mediastinal nodes as markers of involvement by non-small cell lung cancer. Am. Rev. Resp. Dis. 146:1992;1210.
22. Patterson G.A., Ginsberg R.J., Poon P.Y., et al. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in preoperative assessment of mediastinal node status in bronchogenic carcinoma. J. Thorac. Cardiovasc. Surg. 94:1987;679.
23. Laurent F., Drouillard J., Dorcier F., et al. Bronchogenic carcinoma staging. CT versus MR imaging assessment with surgery. Eur. J. Cardiothorac. Surg. 2:1988;31.
24. Kernstine K.H., Stanford W., Mullan B.F., et al. CT and MRI with combidex for mediastinal staging in non-small cell lung carcinoma. Ann. Thorac. Surg. 68:1999;1022.
25. Crisci R., Di Cesare E., Lupattelli L., et al. MR study of N2 disease in lung cancer contrast-enhanced method using gadolinium-DTPA. Eur. J. Cardiothorac. Surg. 11:1997;214.
26. LeBlanc J.K., Espada R., Ergun G. Non-small cell lung cancer staging techniques and endoscopic ultrasound tissue is still the issue. Chest. 123:2003;1718.
27. DeMeester T.R., Bekerman C., Jospeh J.G., Toscano M.S., Golomb H., Bitran J., Gross N.J., Skinner D.B. Gallium-67 scanning for carcinoma of the lung. J. Thorac. Cardiovasc. Surg. 72:1976;699.
28. Lowe V.J., Naunheim K.S. Positron emission tomography in lung cancer. Ann. Thorac. Surg. 65:1998;1821.
29. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343:2000;254.
30. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small cell lung cancer. Mediastinal staging in the 1990s meta-analytic comparison of PET and CT. Radiology. 213:1999;530.
31. van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small cell lung cancer the PLUS multicentre randomized trial. Lancet. 359:2002;1388.
32. Scott W.J., Shepherd J., Gambhir S.S. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer a decision analysis. Ann. Thorac. Surg. 66:1998;1876.
33. Roberts P.F., Follette D.M., von Haag D., et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann. Thorac. Surg. 70:2000;1154.
34. Graeter T.P., Hellwig D., Hoffmann K., Ukena D., Kirsch C.-M., Schaefers H.-J. Mediastinal lymph node staging in suspected lung cancer comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann. Thorac. Surg. 75:2003;231.
35. Gupta N.C., Graeber G.M., Bishop H.A. Comparative efficacy of positron emission tomography with glucodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (ph node lesions. Chest. 117:2000;773.
36. Cerfolio R.J., Ojha B., Mukherjee S., Pask A.H., Bass C.S., Katholi C.R. Positron emission tomography scanning with 2-fluoro-2-deoxy-D-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J. Thorac. Cardiovasc. Surg. 125:2003;938.
37. Blum J.E., Handmaker H., Rinne N.A. The utility of a somatostatin-type receptor binding peptide in the evaluation of solitary pulmonary nodules. Chest. 115:1999;224.
38. 99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest. 117:2000;1232.
39. 18FDG in the staging of non-small cell lung cancer. Eur. Resp. J. 10:1997;2529.
40. Valk P.E., Pounds T.R., Hopkins D.M., et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann. Thorac. Surg. 60:1995;1573.
41. Canadian Lung Oncology Group. Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. Ann. Thorac. Surg. 71:2001;425.
42. Salathe M., Soler M., Bolliger C.T., et al. Transbronchial needle aspiration in routine fiberoptic bronchoscopy. Respiration. 59:1992;5.
43. Wang K.P. Transbronchial needle aspiration and percutaneous needle aspiration for staging and diagnosis of lung cancer. Clin. Chest Med. 16:1995;535.
44. Harrow W.M., Wang K.P. The staging of lung cancer by bronchoscopic transbronchial needle aspiration. Chest Surg. Clin. North Am. 6:1996;223.
45. Toloza E.M., Harpole L., Detterbeck F., McCrory D.C. Invasive staging of non-small cell lung cancer a review of the current evidence. Chest. 123:2003;157S.
46. Rong F., Cui B. CT scan-directed transbronchial needle aspiration biopsy for mediastinal nodes. Chest. 114:1998;36.
47. Garpestad E., Goldberg S.N., Herth F. CT fluoroscopy guidance for transbronchial needle aspiration an experience in 35 patients. Chest. 119:2001;329.
48. Shannon J.J., Bude R.O., Orens J.B., et al. Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy. Am. J. Resp. Crit. Care Med. 153:1996;1424.
49. Detterbeck F.C., DeCamp M.M., Kohman L.J., Silvestri G.A. Invasive staging the guidelines. Chest. 123:2003;167S.
50. Belfiore G., Camer L., Moggio G., et al. Middle mediastinum lesions preliminary experience with CT-guided fine-needle aspiration biopsy with a suprasternal approach. Radiology. 202:1997;870.
51. DeCamp M.M., Mentzer S.J., Swanson S.J., Sugarbaker D.J. Malignant effusive disease of the pleura and pericardium. Chest. 112:1997;291.
52. Gress F.G., Savides T.J., Sandler A., et al. Endoscopic ultrasonography, fine-needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small cell lung cancer a comparison study. Ann. Intern. Med. 127:1997;604.
53. Fritscher-Ravens A., Soehendra N., Schirrow L., et al. Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer. Chest. 117:2000;339.
54. Lee N., Inoue K., Yamamoto R., et al. Patterns of internal echoes in lymph nodes in the diagnosis of lung cancer metastases. World J. Surg. 16:1992;986.
55. Barker J.M., Silvestri G.A. Lung cancer staging. Curr. Opin. Pulmon. Med. 8:2002;287.
56. Cybulsky I.J., Bennett W.F. Mediastinoscopy as a routine outpatient procedure. Ann. Thorac. Surg. 58:1994;176.
57. Coughlin M., Deslauriers J., Beaulieu M., et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann. Thorac. Surg. 40:1985;556.
58. Hammoud Z.T., Anderson R.C., Meyers B.F., et al. The current role of mediastinoscopy in the evaluation of thoracic disease. J. Thorac. Cardiovasc. Surg. 1999;894.
59. Jolly P.C., Hutchinson C.H., Detterbeck F., et al. Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer. J. Thorac. Cardiovasc. Surg. 102:1991;266.
60. Canadian Lung Oncology Group. Investigation for mediastinal disease in patients with apparently operable lung cancer. Ann. Thorac. Surg. 60:1995;1382.
61. Sugarbaker D.J., Strauss G.M. Advances in surgical staging and therapy of non-small cell lung cancer. Semin. Oncol. 20:1993;163.
62. Ginsberg R.J., Rice T.W., Goldberg M., et al. Extended cervical mediastinoscopy a single staging procedure for bronchogenic carcinoma of the left upper lobe. J. Thorac. Cardiovasc. Surg. 94:1987;673.
63. Freixinet Gilart J., Garcia P.G., de Castro F.R., et al. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma. Ann. Thorac. Surg. 70:2000;1641.
64. Best L.A., Munichor M., Ben-Shakhar M., et al. The contribution of anterior mediastinotomy in the diagnosis and evaluation of diseases of the mediastinum and lung. Ann. Thorac. Surg. 43:1987;78.
65. Deneffe G., Lacquet L.M., Gysele A. Cervical mediastinoscopy and anterior mediastinotomy in patients with lung cancer and radiologically normal mediastinum. Eur. J. Resp. Dis. 64:1983;613.
66. Sihoe A.D.L., Yim A.P.C. Video-assisted thoracic surgery as a diagnostic tool. Shields T.W., et al. General Thoracic Surgery. 6th ed. 2003;Lippincott Williams & Wilkins, Philadelphia.
67. Yim A.P.C., Izzat M.B., Lee T.W., Wan S. Video-assisted thoracic surgery a renaissance in surgical therapy. Respirology. 4:1999;1.
68. Yim A.P.C. Thoracoscopy and video-assisted thoracic surgery. Curr. Opin. Pulmon. Med. 5:1999;256.
69. Yim A.P.C., Lee T.W., Ng C.S.H., Sihoe A.D.L., Wan S. Place of video-thoracoscopy in thoracic surgical practice. World J. Surg. 25:2001;157.
70. Yim A.P.C. VATS major pulmonary resection revisited controversies, techniques and results. Ann. Thorac. Surg. 74:2002;615.
71. DeCamp M.M., Jaklitsch M.T., Mentzer S.J., Harpole D.H., Sugarbaker D.J. The safety and versatility of video-thoracoscopy a prospective analysis of 895 consecutive patients. J. Am. Coll. Surg. 181:1995;113.
72. Roviaro G., Varoli F., Rebuffat C., et al. Video-thoracoscopic staging and treatment of lung cancer. Ann. Thorac. Surg. 59:1995;971.
73. Loscertales J., et al. Usefulness of videothoracoscopic intrapericardial examination of pulmonary vessels to identify resectable clinical T4 lung cancer. Ann. Thorac. Surg. 73:2002;1563.
74. Nakanishi R., Mitsudomi T., Osaki T. Combined thoracoscopy and mediastinoscopy for the evaluation of mediastinal lymph node metastases in left upper lobe lung cancer. J. Thorac. Cardiovasc. Surg. 35:1994;347.
75. Ishida T., Ishii T., Yamazaki K., et al. Thoracoscopic limited resection of bronchogenic carcinoma in patients over the age of 80. Int. Surg. 81:1996;237.
76. Ghosn P., Rabbat A., Gariepy G. "Staging" thoracique par videothoracoscoie nouvelle technique. Ann. Chir. 48:1994;773.
77. Sagawa M., et al. A prospective trial of systemic nodal dissection for lung cancer by video-assisted thoracic surgery can it be perfect? Ann. Thorac. Surg. 73:2002;900.
78. Sonett J.R., Krasna M.J. Thoracoscopic staging for intrathoracic malignancy. Yim A.P.C., Hazelrigg S.R., Izzat M.B., et al. Minimal-Access Cardiothoracic Surgery. 2000;183-193 Saunders, Philadelphia.
79. Asamura H., Nakayama H., Kondo H., et al. Thoracoscopic evaluation of histologically/cytologically proven or suspected lung cancer a VATS exploration. Lung Cancer. 16:1997;183.
80. Loscertales J., Garcia Diaz F., Jimenez Merchan R., et al. Valoracion de la resecabilidad del cancer de pulmon mediante videotoracoscopia exploradora. Arch. Bronconeumol. 32:1996;275.
81. Roviaro G.C., Varoli F., Rebuffat C., et al. Videothoracoscopic operative staging for lung cancer. Int. Surg. 81:1996;252.
82. Wain J.C. Video-assisted thoracoscopy and the staging of lung cancer. Ann. Thorac. Surg. 56:1993;776.
83. Yim A.P.C. Routine video-assisted thoracoscopy prior to thoracotomy. Chest. 109:1996;1099.
84. Passlick B., Kubuschock B., Sienel W., Thetter O., Pantel K., et al. Mediastinal lymphadenectomy in non-small cell lung cancer. Effectiveness in patients with or without nodal micrometastases results of a preliminary study. Eur. J. Cardiothorac. Surg. 21:2002;520.
85. Naruke T., Tsuchiya R., Kondo H., Nakayama H., Asamura H. Lymph node sampling in lung cancer how should it be done? Eur. J. Cardiothorac. Surg. 16:1999;17.
86. Izbicki J.R., Thetter O., Habekost M., Karg O., Passlick B., et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer a randomized controlled trial. Br. J. Surg. 81:1994;229.
87. Kubuschock B., Passlick B., Izbicki J.R., Thetter O., Pantel K., et al. Disseminated tumor cells as a determinant for survival in surgically resected non-small cell lung cancer. J. Clin. Oncol. 17:1999;19.
88. Riquet M., Manac'h D., Pimpec-Barthes F., Dujon A., Chehab A., et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann. Thorac. Surg. 67:1999;1572.
89. Yoshino I., Yokoyama H., Yano T., Ueda T., Takai E., et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann. Thorac. Surg. 62:1996;1021.
90. Little A.G., DeHoyos A., Kirgan D.M., Arcomano T.R., Murray K.D., et al. Intraoperative lymphatic mapping for non-small cell lung cancer the sentinel node technique. J. Thorac. Cardiovasc. Surg. 117:1999;220.
91. Liptay M.J., Masters G.A., Winchester D.J., Edelman B.L., Garrido B.J., et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann. Thorac. Surg. 70:2000;384.
92. Miller W.E., Taylor A.M. Biopsy of scalene and supraclavicular lymph nodes value in diagnosis. Cleve. Clin. Q. 32:1965;205.
93. Daniels A.C. A method of biopsy useful in diagnosing certain intrathoracic diseae. Dis. Chest. 16:1949;360.
94. Conn J.H., Fain W.R., Chavez C.M., et al. A critical evaluation of scalene lymphadenectomy in 500 patients. Am. Surg. 35:1969;125.
95. Rohwedder J.J., Handley J.A., Kerr D. Rapid diagnosis of lung cancer from palpable metastases by needle thrust. Chest. 98:1990;1393.
96. Skinner D.B. Scalene-lymph-node biopsy reappraisal of risks and indications. N. Engl. J. Med. 268:1963;1324.
97. Pualwan F.A., Sherman C.D. Jr, Emerson G.L., DeWeese J.A., Schwartz S.I., Watson B.E. Scalene node biopsy implications in abdominal and thoracic disease. Cancer. 11:1958;4.
98. Rochlin D.B., Enterline H.T. Prescalene lymph node biopsies. Am. J. Surg. 96:1958;372.
99. Lee J.D., Ginsberg R.J. Lung cancer staging the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Ann. Thorac. Surg. 62:1996;338.
100. Bruneton J.N., Roux P., Caramella E., Demard F., Vallicioni J., Chauvel P. Ear, nose, and throat cancer ultrasound diagnosis of metastasis to cervical lymph nodes. Radiology. 152:1984;771.
101. Hajek P.C., Salomonowitz E., Turk R., Tscholakoff D., Kumpan W., Czembirek H. Lymph nodes of the neck evaluation with US. Radiology. 158:1986;739.
102. Sakai F., Kiyono K., Sone S., Kondo Y., Oguchi M., Watanabe T., et al. Ultrasonic evaluation of cervical metastatic lymphadenopathy. J. Ultrasound Med. 7:1988;305.
103. Fultz P.J., Feins R.H., Strang J.G., Wandtke J.C., Johnstone D.W., Watson T.J., Gottlieb R.H., Voci S.L., Rubens D.J. Detection and diagnosis of nonpalpable supraclavicular lymph nodes in lung cancer at CT and US. Radiology. 222:2002;245.
104. Chang D.B., Yang P.C., Yu C.J., Kuo S.H., Lee Y.C., Luh K.T. Ultrasonography and ultrasonographically guided fine-needle aspiration biopsy of impalpable cervical lymph nodes in patient with non-small cell lung cancer. Cancer. 70:1992;1111.
105. Ahuja A.T., Chow L., Chick W., King W., Metreweli C. Metastatic cervical nodes in papillary carcinoma of the thyroid ultrasound and histological correlation. Clin. Radiol. 50:1995;229.
106. Ahuja A., Ying M., King W., Metreweli C. A practical approach to the ultrasound of cervical lymph nodes. J. Laryngol. Otol. 111:1997;245.
107. Ahuja A.T., Ying M., Ho S.S., Metreweli C. Distribution of intranodal vessels in differentiating benign from metastatic neck nodes. Clin. Radiol. 56:2001;197.
108. Sihoe, A. D. L., Lee, T. W., Ahuja, A. T. and Yim, A. P. C. Should cervical ultrasonography be a routine staging investigation for lung cancer patients with impalpable cervical lymph nodes? Eur. J. Cardiothorac. Surg. 2003 (in press).
109. Naruke T., Tsuchiya R., Kondo H., Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM staging classification the Japanese experience. Ann. Thorac. Surg. 71:2001;1759.
110. Putnam J.B. The anatomic basis for lung cancer staging the end of the beginning? Ann. Thorac. Surg. 71:2001;1757.
111. D'Amico T.A. Molecular biologic substaging of non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 123:2002;409.
112. Lau C.L., Moore M.B., Brooks K.R., D'Amico T.A., Harpole D.H. Molecular staging of lung and esophageal cancer. Surg. Clin. North Am. 82:2002;497.
113. D'Amico T.A., Aloia T.A., Moore M.B., Herndon J.E., Brooks K.R., Lau C.L., et al. Molecular biologic substaging of stage I lung cancer according to gender and histology. Ann. Thorac. Surg. 69:2000;882.
114. Kwaitkowski D.J., Harpole D.H., Godleski J., Herndon J.E. II, Shieh D.-B., Richards W., Blanco R., Xu H.-J., Strauss G.M., Sugarbaker D.J. Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients clinical implications. J. Clin. Oncol. 16:1998;2468.
115. D'Amico T.A., Massey M., Herndon J.E., Moore M.-B., Harpole D.H. A biologic risk model for stage I lung cancer immunohistochemical analysis of 408 patients with the use of 10 molecular markers. J. Thorac. Cardiovasc. Surg. 117:1999;736.
116. Iyengar P., Tsao M.-S. Clinical relevance of molecular markers in lung cancer. Surg. Oncol. 11:2002;167.
117. Greatens T.M., Niehans G.A., Rubins J.B., et al. Do molecular markers predict survival in non-small cell lung cancer? Am. J. Resp. Crit. Care Med. 157:1998;1093.
118. Quinlan D.C., Davidson A.G., Summers C.L., et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res. 52:1992;4828.
119. Fujino M., Dosaka-Akita H., Harada M., et al. Prognostic significance of p53 and ras p21 expression in non-small cell lung cancer. Cancer. 76:1995;2457.
120. Harpole D.H. Jr, Marks J.R., et al. Localized adenocarcinoma of the lung oncogene expression of erbB-2 and p53 in 150 patients. Clin. Cancer Res. 1:1995;659.
121. Horio Y., Takahashi T., Kuroishi T., et al. Prognostic significance of p53 mutations and 3p deletions in primarily resected non-small cell lung cancer. Cancer Res. 53:1993;1.
122. Mitsudomi T., Oyama T., Kusano T., et al. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J. Natl. Cancer Inst. 85:1993;20l8A.
123. McLaren R., Kuzu I., Dunnill M., et al. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer. 66:1992;735.
124. Lee J.S., Yoon A., Kalapurakal S.K., et al. Expression of p53 oncoprotein in non-small cell lung cancer a favorable prognostic factor. J. Clin. Oncol. 13:1995;1893.
125. Passlick B., Izbicki J.R., Haussinger K., et al. Immunohistochemical detection of p53 is not associated with a poor prognosis in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 109:1995;1205.
126. Slebos R.J.C., Kibbelaar R., Dalesio I., et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med. 323:1990;561.
127. Fukuyama Y., Mitsudomi T., Sugio K., et al. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small cell lung cancer. Br. J. Cancer. 75:1997;1125.
128. Harada M., Dosaka-Akita H., Miyamoto H., et al. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer. Cancer. 69:1992;72.
129. Pastorino U., Andreola S., Tagliabue E., et al. Immunohistochemical markers in stage I lung cancer relevance to prognosis. J. Clin. Oncol. 15:1997;2858.
130. Kem J.A., Schwartz D.A., Nordberg J.E., et al. P1 85neu expression in human lung adenocarcinoma predicts shortened survival. Cancer Res. 50:1990;5184.
131. Pezzella F., Turley H., Kuzu I., et al. Bcl-2 protein in non-small cell lung carcinoma. N. Engl. J. Med. 329:1993;690.
132. Fontanini G., Vignati S., Bigini D., et al. Bcl-2 protein a prognostic factor inversely correlated to p53 in non-small- cell lung cancer. Br. J. Cancer. 71:1995;1003.
133. Xu H.-J., Quinlan D.C., Davidson A.G., et al. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. Natl. Cancer Inst. 86:1994;695.
134. Ng C.S., Zhang J., Wan S., Lee T.W., Arifi A.A., Mok T., Lo D.Y., Yim A.P. Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer. J. Surg. Oncol. 79:2002;101.
135. Mishina T., Dosaka-Akita H., Hommura F., Nishi M., Kojima T., Ogura S., Shimizu M., Katoh H., Kawakami Y. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin. Cancer Res. 6:(11-):2000;16.
136. Fukuse T., Hirata T., Naiki H., Hitomi S., Wada H. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Res. 60:2000;242.
137. Mueller-Tidow C., Metzger R., Kugler K., Diederichs S., Idos G., Thomas M., Dockhorn-Dworniczak B., Schneider P.M., Koeffler P., Berdel W.E., Serve H. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res. 61:2001;647.
138. Dosaka-Akita H., Hommura F., Mishina T., Ogura S., Shimizu M., Katoh H., Kawakami Y. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p2l different roles of GI cyclins in cell proliferation and prognosis. Cancer Res. 61:2001;2500.
139. Takanami I., Tanana F., Hashizume T., Kikuchi K., Yamamoto Y., Yamamoto T., Kodaira S. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas an evaluation of their expression as prognostic markers. Oncology. 53:1996;392.
140. Hara H., Yamashita K., Shinada J., Yoshimura H., Kameya T. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Lung Cancer. 34:2001;219.
141. Harpole D.H. Jr, Herndon J.E. II, Young W.G., Wolf W.G., Sabiston D.C. Jr. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology and oncoprotein expression. Cancer Res. 55:1995;51.
142. Harpole D.H., Richards W.G., Herndon J.E., et al. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann. Thorac. Surg. 61:1996;1470.
143. Pence J.C., Kerns B.M., Dodge R.K., et al. Prognostic significance of the proliferation index in surgically resected non-small cell lung cancer. Arch. Surg. 128:1993;1382.
144. Macchiarini P., Fontanini G.M., Hardin M.J., et al. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet. 3240:1992;145.
145. Imoto H., Osaki T., Taga S., et al. Vascular endothelial growth factor expression in non-small cell lung cancer prognostic significance in squamous cell carcinoma. J. Thorac. Cardiovasc. Surg. 115:1998;1007.
146. Liao M., Wang H., Lin Z., et al. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer. 33:2001;125.
147. Choi J.H., Kim H.C., Lim H.Y. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer correlation with platelet and leukocyte counts. Lung Cancer. 33:2001;171.
148. Tamura M., Ohta Y., Kajita T., et al. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Oncol. Rep. 8:2001;1097.
149. Fontanini G., Lucchi M., Vignati S., et al. Angiogenesis as a prognostic indicator of survival in non-small cell lung cancer. J. Natl. Cancer Inst. 89:1997;881.
150. Yoshino H., Endo Y., Watanabe Y., et al. Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br. J. Cancer. 78:1998;833.
151. Pedersen H., Brunner N., Francis D., et al. Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in lung cancer. Cancer Res. 54:1994;4671.
152. Strauss G.M. Prognostic markers in resectable non-small cell lung cancer. Hematol. Oncol. Clin. North Am. 1:1997;409.
153. Sukoh N., Abe S., Ogura S., et al. Immunohistochemical study of cathepsin B prognostic significance in human lung cancer. Cancer. 74:1994;46.
154. Mori M., Kohli A., Baker S.P., et al. Laminin and cathepsin B as a prognostic factor in stage I non-small cell lung cancer are they useful? Mod. Pathol. 10:1997;572.
155. Maruyama R., Sugio K., Mitsudomi T., et al. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 144:1997;535.
156. Pantel K., Izbicki J.R., Passlick B., et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet. 347:1996;649.
157. Salerno C., Frizelle S., Niehans G., et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase- polymerase chain reaction. Chest. 113:1998;1526.
158. D'Cunha J., Corfits A.L., Herndon J.E., Kern J.A., Kohman L.J., Patterson G.A., Kartzke R.A., Maddaus M.A. Molecular staging of lung cancer real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer. Preliminary results of cancer and leukemia group B trial 9761. J. Thorac. Cardiovasc. Surg. 123:2002;484.